Skip to main content

Actors and Networks database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Additional complementary work by other organisations on GCT stakeholders mapping can be found here.

A scientific paper on actors has also been published in Humanities and Social Sciences Communications. You can find its lay summary here.

Showing 10 of 384

Belgian Federal Agency for Medicines and Health Products (Agence fédérale des médicaments et des produits de santé / Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten) (FAMHP / AFMPS / FAGG)

Region/Country:  
  • Countries in the EU/EEA
  • Belgium

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Medical Devices Entities
  • Medical Device Authorities
  • National Medical Device Authorities
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Additional information

The FAMHP is the Belgian competent authority in charge of ensuring the quality, safety and efficacy of medicines and health products (medical devices and accessories, raw materials, blood and blood components of human origin, human tissue material), for human and veterinary use, in clinical development and on the market.

Belgian Health Care Knowledge Centre (Federaal Kenniscentrum voor de Gezondheidszorg / Centre Fédéral d’expertise des Soins de Santé) (KCE)

Region/Country:  
  • Countries in the EU/EEA
  • Belgium

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

Belgian Intellectual Property Office (Office belge de la Propriété intellectuelle / Belgische Dienst voor de Intellectuele Eigendom) (IPObel / OPRI / DIE)

Region/Country:  
  • Countries in the EU/EEA
  • Belgium

Type of Actor:

  • Regulators
  • Patent Offices
  • National Patent Offices

Development Stage:

  • Fundamental Research

Belgian National Institute for Health and Disability Insurance (Rijksinstituut voor Ziekte- en Invaliditeitsverzekering / Institut National d’assurance Maladie-Invalidité) (RIZIV / INAMI)

Region/Country:  
  • Countries in the EU/EEA
  • Belgium

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

Benelux Office for Intellectual Property (Belgium, Netherlands and Luxembourg) (BOIP)

Region/Country:  
  • Countries in the EU/EEA
  • Belgium
  • Netherlands
  • Luxembourg

Type of Actor:

  • Regulators
  • Patent Offices
  • Supranational Patent Offices

Development Stage:

  • Fundamental Research

Beneluxa Initiative

Region/Country:  
  • Countries in the EU/EEA
  • Belgium
  • Netherlands
  • Luxembourg

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

Berlin Cert Prüf- und Zertifizierstelle für Medizinprodukte GmbH

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

Berlin Institute of Health at Charite (BIH)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Non-profit Research Organisations
  • Translational Centres

Development Stage:

  • Translational Research

Additional information

The mission of the Berlin Institute of Health (BIH) is medical translation: transferring biomedical research findings into novel approaches to personalized prediction, prevention, diagnostics and therapy and, conversely, using clinical observations to develop new research ideas.

British Medicines and Healthcare products Regulatory Agency (MHRA)

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Medical Devices Entities
  • Medical Device Authorities
  • National Medical Device Authorities
  • Other National competent authorities
  • Competent Authorities for Blood and Blood Components
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Bruxelles Environnement / Leefmilieu Brussel

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts